Benchling

“Our main product at the end of our process is the data. Having that data integrity,  leveraging Benchling, really allows us to look at a larger sample size and make data driven decisions.”

“The timeline is a huge selling point for customers right now … It's a combination of a lot of  processes that have improved. But PipeBio really enabled that scaled work.”

“It enables scientists to analyze their own data. Rather than waiting several weeks to build a  custom pipeline, they can configure it to what they need without my team’s involvement, which is amazing.”

““I will very much look forward to seeing how we, together as Novonesis with Benchling, can leverage this information and this innovation power together, in order to create impactful biosolutions of tomorrow.””

““I'm really optimistic that through our collaboration, Novonesis and Benchling can find great solutions for structuring our data. That will free up valuable time, allowing for more time spent in the lab, finding promising biological solutions of our own,” reflects Mary Stringer, Science Manager, at Novonesis.”

““It's important to us to have FAIR data so that we can make sure that different parts of our R&D organization can work together and exchange data in an efficient way,” says Vignir.”

““With a centralized system, we are able to host all of the relevant information in one place. This means that users no longer have to switch from one system to another,” explains Marzena Gozdecka, R&D IT System Specialist at Novonesis. “The centrality of the data storage and accessibility is a huge advantage".”

““If you are managing an R&D organization, you're very focused on your return on investment. The more we can do to limit the cost factor by having efficient systems to support our scientists, the better."”

““I think it’s important to have a method software that is easy to use so that people want to use it”, asserts Gemma Lindemann, Associate Scientist at Novonesis. “That allows for the biggest impact.””

““When we started using the Benchling notebook, we saw an opportunity to consolidate many of the tools into one,” shares Vignir Isberg, Senior Department Manager at Novonesis.”

““Our R&D goals at Novonesis are more ambitious than ever, and a strong digital strategy is essential for achieving them,” says Martin S. Borchert, Sr. Director, Scientific Data Strategy and Systems at Novonesis. “The extension of our partnership with Benchling sets us up to work at speed and scale. We’re able to automate key aspects of R&D and create a unified foundation for advanced data tooling. Thanks to AI-ready data and integrated systems, we can apply machine learning techniques to our work today.””